Industries > Pharma > Amino Acid Metabolism Disorders Treatment Market Report to 2031
Amino Acid Metabolism Disorders Treatment Market Report to 2031
Forecasts by Product Type (Folic Acid, Vitamin B6&B12, Arginine, Thiamine, Vitamin D, Betaine, Sapropterin Dihydrochloride, and Carglumic Acid), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Stores) PLUS COVID-19 Recovery Scenarios
Amino Acid Metabolism Disorders Treatment Market – our new study reveals trends, R&D progress, and predicted revenues
Where is the Amino Acid Metabolism Disorders Treatment market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenue streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
500+ page report provides 600+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and future market prospects. Our new study lets you assess forecasted sales at the overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Amino Acid Metabolism Disorders Treatment Market. See how to exploit opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), product profiles, and commercial developments.
Discover sales predictions for the world market and submarkets
Amino Acid Metabolism Disorders Treatment Market: By Product Type
• Folic Acid
• Vitamin B6&B12
• Arginine
• Thiamine
• Vitamin D
• Betaine
• Sapropterin Dihydrochloride
• Carglumic Acid
Amino Acid Metabolism Disorders Treatment Market: By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Stores
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Amino Acid Metabolism Disorders Treatment Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Amino Acid Metabolism Disorders Treatment Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Amino Acid Metabolism Disorders Treatment Market report helps you
In summary, our 500+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Amino Acid Metabolism Disorders Treatment Market, with forecasts for Product Type and Distribution Channel, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Amino Acid Metabolism Disorders Treatment market in North America, Europe, Asia-Pacific, and Rest of the World. Also forecasted are the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for xx of the major companies involved in the Amino Acid Metabolism Disorders Treatment Market. Some of the companies profiled in this report include GlaxoSmithKline PLC, Pfizer, Inc., AMINO GmbH, Merck KGaA, Recordati S.p.A., Koninklijke DSM N.V., Sanofi, Shine Star (Hubei) Biological Engineering Co., Civentichem, LLC, Ltd., and Kyowa Hakko Kirin Co., Ltd.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Amino Acid Metabolism Disorders Treatment Market Report to 2031: Forecasts by Product Type (Folic Acid, Vitamin B6&B12, Arginine, Thiamine, Vitamin D, Betaine, Sapropterin Dihydrochloride, and Carglumic Acid), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Stores) PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Amino Acid Metabolism Disorders Treatment Market
2.1. Amino Acid Metabolism Disorders Treatment Market Definition
2.2. Product Type Submarkets Definitions
2.3. Distribution Channel Submarkets Definitions
3. Amino Acid Metabolism Disorders Treatment Market Overview
3.1. Global Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Region
3.2. Global Amino Acid Metabolism Disorders Treatment Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Wider availability of Treatment
3.3.1.2. Increasing Per Capita Healthcare Expenditure
3.3.1.3. Rise in the prevalence of chronic disorders
3.3.1.4. Presence for strong product pipeline
3.3.2. Market Restraints/Challenges
3.3.2.1. High Cost of Treatment
3.3.3. Opportunities
3.3.3.1. Exploring new disease indications
3.3.3.2. Technological Advancements
3.3.3.3. Promising emerging economies
3.3.4. Global Amino Acid Metabolism Disorders Treatment Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. The threat of New Entry
4. Global Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast, 2021-2031 by Product Type (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Folic Acid
4.1.2. Vitamin B6&B12
4.1.3. Arginine
4.1.4. Thiamine
4.1.5. Vitamin D
4.1.6. Betaine
4.1.7. Sapropterin Dihydrochloride
4.1.8. Carglumic Acid
5. Global Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast, 2021-2031 by Distribution Channel (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Hospital Pharmacies
5.1.2. Retail Pharmacies
5.1.3. Online Stores
6. North America Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
6.1. Market Overview
6.2. North America Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Product Type
6.3. North America Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Distribution Channel
6.4. U.S. Amino Acid Metabolism Disorders Treatment Market
6.5. Canada Amino Acid Metabolism Disorders Treatment Market
7. Europe Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. Europe Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Product Type
7.3. Europe Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Distribution Channel
7.4. UK Amino Acid Metabolism Disorders Treatment Market
7.5. Germany Amino Acid Metabolism Disorders Treatment Market
7.6. France Amino Acid Metabolism Disorders Treatment Market
7.7. Rest of Europe Amino Acid Metabolism Disorders Treatment Market
8. Asia Pacific Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Asia Pacific Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Product Type
8.3. Asia Pacific Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Distribution Channel
8.4. China Amino Acid Metabolism Disorders Treatment Market
8.5. India Amino Acid Metabolism Disorders Treatment Market
8.6. Japan Amino Acid Metabolism Disorders Treatment Market
8.7. Rest of Asia Pacific Amino Acid Metabolism Disorders Treatment Market
9. Latin America Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Latin America Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Product Type
9.3. Latin America Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Distribution Channel
9.3.1. Brazil Amino Acid Metabolism Disorders Treatment Market
9.3.2. Mexico Amino Acid Metabolism Disorders Treatment Market
9.3.3. Rest of Latin America Amino Acid Metabolism Disorders Treatment Market
10. MEA Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. MEA Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Product Type
10.3. MEA Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Distribution Channel
10.4. GCC Amino Acid Metabolism Disorders Treatment Market
10.5. South Africa Amino Acid Metabolism Disorders Treatment Market
10.6. Rest of MEA Amino Acid Metabolism Disorders Treatment Market
11. Companies in the Amino Acid Metabolism Disorders Treatment Market
11.1. GlaxoSmithKline PLC
11.1.1. Company Snapshot
11.1.2. Company Overview
11.1.3. Financial Performance (2015-2019)
11.1.3.1. Net Revenue
11.1.3.2. Gross Profit
11.1.3.3. Geographical Revenue, 2019
11.1.4. Product Offerings
11.1.5. Recent Initiatives (2017-2019)
11.2. Pfizer, Inc.
11.2.1. Company Snapshot
11.2.2. Company Overview
11.2.3. Financial Performance (2015-2019)
11.2.3.1. Net Revenue
11.2.3.2. Gross Profit
11.2.3.3. Geographical Revenue, 2019
11.2.4. Product Offerings
11.2.5. Recent Initiatives (2017-2019)
11.3. AMINO GmbH
11.3.1. Company Snapshot
11.3.2. Company Overview
11.3.3. Financial Performance (2015-2019)
11.3.3.1. Net Revenue
11.3.3.2. Gross Profit
11.3.3.3. Geographical Revenue, 2019
11.3.4. Product Offerings
11.3.5. Recent Initiatives (2017-2019)
11.4. Merck KGaA
11.4.1. Company Snapshot
11.4.2. Company Overview
11.4.3. Financial Performance (2015-2019)
11.4.3.1. Net Revenue
11.4.3.2. Gross Profit
11.4.3.3. Geographical Revenue, 2019
11.4.4. Product Offerings
11.4.5. Recent Initiatives (2017-2019)
11.5. Recordati S.p.A.
11.5.1. Company Snapshot
11.5.2. Company Overview
11.5.3. Financial Performance (2015-2019)
11.5.3.1. Net Revenue
11.5.3.2. Gross Profit
11.5.3.3. Geographical Revenue, 2019
11.5.4. Product Offerings
11.5.5. Recent Initiatives (2017-2019)
11.6. Koninklijke DSM N.V.
11.6.1. Company Snapshot
11.6.2. Company Overview
11.6.3. Financial Performance (2015-2019)
11.6.3.1. Net Revenue
11.6.3.2. Gross Profit
11.6.3.3. Geographical Revenue, 2019
11.6.4. Product Offerings
11.6.5. Recent Initiatives (2017-2019)
11.7. Sanofi
11.7.1. Company Snapshot
11.7.2. Company Overview
11.7.3. Financial Performance (2015-2019)
11.7.3.1. Net Revenue
11.7.3.2. Gross Profit
11.7.3.3. Geographical Revenue, 2019
11.7.4. Product Offerings
11.7.5. Recent Initiatives (2017-2019)
11.8. Shine Star (Hubei) Biological Engineering Co.
11.8.1. Company Snapshot
11.8.2. Company Overview
11.8.3. Financial Performance (2015-2019)
11.8.3.1. Net Revenue
11.8.3.2. Gross Profit
11.8.3.3. Geographical Revenue, 2019
11.8.4. Product Offerings
11.8.5. Recent Initiatives (2017-2019)
11.9. Civentichem, LLC
11.9.1. Company Snapshot
11.9.2. Company Overview
11.9.3. Financial Performance (2015-2019)
11.9.3.1. Net Revenue
11.9.3.2. Gross Profit
11.9.3.3. Geographical Revenue, 2019
11.9.4. Product Offerings
11.9.5. Recent Initiatives (2017-2019)
11.10. Kyowa Hakko Kirin Co., Ltd.
11.10.1. Company Snapshot
11.10.2. Company Overview
11.10.3. Financial Performance (2015-2019)
11.10.3.1. Net Revenue
11.10.3.2. Gross Profit
11.10.3.3. Geographical Revenue, 2019
11.10.4. Product Offerings
11.10.5. Recent Initiatives (2017-2019)
11.11. Other Notable Players
12. Conclusion
13. Glossary
Associated Visiongain Reports
Visiongain Report Sales Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6 Amino Acid Metabolism Disorders Treatment Market Drivers & Restraints 2020
Table 7 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 8 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 9 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 10 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 11 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 12 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17 Vitamin B6&B12 Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 18 Vitamin B6&B12 Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 19 Vitamin B6&B12 Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 20 Vitamin B6&B12 Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 21 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 22 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 23 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 24 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 25 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 26 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 27 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 28 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 29 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 30 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 31 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 32 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 33 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 34 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 35 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 36 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 37 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 38 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 39 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 40 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 41 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 42 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 43 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 44 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 45 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 46 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 47 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 48 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 49 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 50 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 51 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 52 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 53 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 54 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 55 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 56 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 57 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 58 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 59 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 60 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 61 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 62 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 63 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 64 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 65 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 66 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 67 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 68 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 69 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 70 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 71 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 72 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 73 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 74 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 75 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 76 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 77 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 78 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 79 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 80 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 81 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 82 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 83 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 84 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 85 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 86 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 87 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 88 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 89 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 90 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 91 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 92 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 93 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 94 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 95 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 96 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 97 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 98 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 99 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 100 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 101 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 102 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 103 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 104 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 105 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 106 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 107 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 108 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 109 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 110 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 111 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 112 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 113 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 114 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 115 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 116 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 117 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 118 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 119 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 120 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 121 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 122 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 123 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 124 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 125 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 126 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 127 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 128 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 129 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 130 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 131 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 132 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 133 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 134 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 135 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 136 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 137 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 138 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 139 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 140 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 141 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 142 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 143 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 144 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 145 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 146 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 147 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 148 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 149 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 150 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 151 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 152 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 153 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 154 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 155 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 156 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 157 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 158 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 159 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 160 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 161 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 162 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 163 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 164 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 165 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 166 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 167 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 168 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 169 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 170 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 171 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 172 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 173 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 174 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 175 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 176 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 177 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 178 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 179 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 180 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 181 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 182 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 183 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 184 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 185 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 186 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 187 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 188 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 189 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 190 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 191 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 192 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 193 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 194 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 195 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 196 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 197 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 198 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 199 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 200 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 201 Leading 10 Amino Acid Metabolism Disorders Treatment Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 202 GlaxoSmithKline PLC Profile 2019 (CEO, HQ, Founded, Website)
Table 203 GlaxoSmithKline PLC Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2019 (Date, Contract Treatment Type, Details)
Table 204 GlaxoSmithKline PLC Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 205 Pfizer, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 206 Pfizer, Inc. Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2019 (Date, Contract Treatment Type, Details)
Table 207 Pfizer, Inc. Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 208 AMINO GmbH Profile 2019 (CEO, HQ, Founded, Website)
Table 209 AMINO GmbH Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2017-2019 (Date, Contract Treatment Type, Details)
Table 210 AMINO GmbH Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 211 Merck KGaA Profile 2019 (CEO, HQ, Founded, Website)
Table 212 Merck KGaA Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2015-2019 (Date, Contract Treatment Type, Details)
Table 213 Merck KGaA Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 214 Recordati S.p.A. Profile 2019 (CEO, HQ, Founded, Website)
Table 215 Recordati S.p.A. Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2015-2019 (Date, Contract Treatment Type, Details)
Table 216 Recordati S.p.A. Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 217 Koninklijke DSM N.V. Profile 2019 (CEO, HQ, Founded, Website)
Table 218 Koninklijke DSM N.V. Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2015-2019 (Date, Contract Treatment Type, Details)
Table 219 Koninklijke DSM N.V. Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 220 Sanofi Profile 2019 (CEO, HQ, Founded, Website)
Table 221 Sanofi Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2015-2019 (Date, Contract Treatment Type, Details)
Table 222 Sanofi Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 223 Shine Star (Hubei) Biological Engineering Co. Profile 2019 (CEO, HQ, Founded, Website)
Table 224 Shine Star (Hubei) Biological Engineering Co. Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2015-2019 (Date, Contract Treatment Type, Details)
Table 225 Shine Star (Hubei) Biological Engineering Co. Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 226 Civentichem, LLC Profile 2019 (CEO, HQ, Founded, Website)
Table 227 Civentichem, LLC Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2015-2019 (Date, Contract Treatment Type, Details)
Table 228 Civentichem, LLC Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 229 Kyowa Hakko Kirin Co., Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 230 Kyowa Hakko Kirin Co., Ltd. Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2015-2019 (Date, Contract Treatment Type, Details)
Table 231 Kyowa Hakko Kirin Co., Ltd. Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 232 Other Companies Involved in the Amino Acid Metabolism Disorders Treatment Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1 Amino Acid Metabolism Disorders Treatment Market By Product Type Overview
Figure 2 Amino Acid Metabolism Disorders Treatment Market By Distribution Channel
Figure 3 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 4 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 5 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 6 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 7 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 8 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 9 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 10 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 11 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 12 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 13 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 14 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 15 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 16 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 17 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 18 Vitamin B6&B12 Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19 Vitamin B6&B12 Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20 Vitamin B6&B12 Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21 Vitamin B6&B12 Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 73 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 74 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 75 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 76 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 77 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 78 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 79 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 80 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 81 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 82 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 83 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 84 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 85 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 86 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 87 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 88 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 89 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 90 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 91 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 92 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 93 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 94 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 95 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 96 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 97 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 98 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 99 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 100 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 101 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 102 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 103 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 104 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 105 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 106 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 107 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 108 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 109 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 110 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 111 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 112 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 113 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 114 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 115 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 116 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 117 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 118 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 119 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 120 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 121 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 122 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 123 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 124 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 125 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 126 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 127 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 128 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 129 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 130 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 131 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 132 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 133 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 134 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 135 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 136 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 137 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 138 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 139 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 140 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 141 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 142 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 143 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 144 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 145 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 146 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 147 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 148 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 149 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 150 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 151 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 152 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 153 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 154 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 155 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 156 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 157 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 158 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 159 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 160 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 161 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 162 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 163 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 164 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 165 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 166 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 167 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 168 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 173 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 183 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 184 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 185 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 186 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 187 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 188 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 189 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 190 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 191 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 192 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 193 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 194 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 195 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 196 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 197 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 198 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 199 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 200 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 201 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Amino Acid Metabolism Disorders Treatment Market
2.1. Amino Acid Metabolism Disorders Treatment Market Definition
2.2. Product Type Submarkets Definitions
2.3. Distribution Channel Submarkets Definitions
3. Amino Acid Metabolism Disorders Treatment Market Overview
3.1. Global Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Region
3.2. Global Amino Acid Metabolism Disorders Treatment Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Wider availability of Treatment
3.3.1.2. Increasing Per Capita Healthcare Expenditure
3.3.1.3. Rise in the prevalence of chronic disorders
3.3.1.4. Presence for strong product pipeline
3.3.2. Market Restraints/Challenges
3.3.2.1. High Cost of Treatment
3.3.3. Opportunities
3.3.3.1. Exploring new disease indications
3.3.3.2. Technological Advancements
3.3.3.3. Promising emerging economies
3.3.4. Global Amino Acid Metabolism Disorders Treatment Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. The threat of New Entry
4. Global Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast, 2021-2031 by Product Type (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Folic Acid
4.1.2. Vitamin B6&B12
4.1.3. Arginine
4.1.4. Thiamine
4.1.5. Vitamin D
4.1.6. Betaine
4.1.7. Sapropterin Dihydrochloride
4.1.8. Carglumic Acid
5. Global Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast, 2021-2031 by Distribution Channel (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Hospital Pharmacies
5.1.2. Retail Pharmacies
5.1.3. Online Stores
6. North America Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
6.1. Market Overview
6.2. North America Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Product Type
6.3. North America Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Distribution Channel
6.4. U.S. Amino Acid Metabolism Disorders Treatment Market
6.5. Canada Amino Acid Metabolism Disorders Treatment Market
7. Europe Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. Europe Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Product Type
7.3. Europe Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Distribution Channel
7.4. UK Amino Acid Metabolism Disorders Treatment Market
7.5. Germany Amino Acid Metabolism Disorders Treatment Market
7.6. France Amino Acid Metabolism Disorders Treatment Market
7.7. Rest of Europe Amino Acid Metabolism Disorders Treatment Market
8. Asia Pacific Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Asia Pacific Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Product Type
8.3. Asia Pacific Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Distribution Channel
8.4. China Amino Acid Metabolism Disorders Treatment Market
8.5. India Amino Acid Metabolism Disorders Treatment Market
8.6. Japan Amino Acid Metabolism Disorders Treatment Market
8.7. Rest of Asia Pacific Amino Acid Metabolism Disorders Treatment Market
9. Latin America Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Latin America Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Product Type
9.3. Latin America Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Distribution Channel
9.3.1. Brazil Amino Acid Metabolism Disorders Treatment Market
9.3.2. Mexico Amino Acid Metabolism Disorders Treatment Market
9.3.3. Rest of Latin America Amino Acid Metabolism Disorders Treatment Market
10. MEA Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. MEA Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Product Type
10.3. MEA Amino Acid Metabolism Disorders Treatment Market Size and Forecast by Distribution Channel
10.4. GCC Amino Acid Metabolism Disorders Treatment Market
10.5. South Africa Amino Acid Metabolism Disorders Treatment Market
10.6. Rest of MEA Amino Acid Metabolism Disorders Treatment Market
11. Companies in the Amino Acid Metabolism Disorders Treatment Market
11.1. GlaxoSmithKline PLC
11.1.1. Company Snapshot
11.1.2. Company Overview
11.1.3. Financial Performance (2015-2019)
11.1.3.1. Net Revenue
11.1.3.2. Gross Profit
11.1.3.3. Geographical Revenue, 2019
11.1.4. Product Offerings
11.1.5. Recent Initiatives (2017-2019)
11.2. Pfizer, Inc.
11.2.1. Company Snapshot
11.2.2. Company Overview
11.2.3. Financial Performance (2015-2019)
11.2.3.1. Net Revenue
11.2.3.2. Gross Profit
11.2.3.3. Geographical Revenue, 2019
11.2.4. Product Offerings
11.2.5. Recent Initiatives (2017-2019)
11.3. AMINO GmbH
11.3.1. Company Snapshot
11.3.2. Company Overview
11.3.3. Financial Performance (2015-2019)
11.3.3.1. Net Revenue
11.3.3.2. Gross Profit
11.3.3.3. Geographical Revenue, 2019
11.3.4. Product Offerings
11.3.5. Recent Initiatives (2017-2019)
11.4. Merck KGaA
11.4.1. Company Snapshot
11.4.2. Company Overview
11.4.3. Financial Performance (2015-2019)
11.4.3.1. Net Revenue
11.4.3.2. Gross Profit
11.4.3.3. Geographical Revenue, 2019
11.4.4. Product Offerings
11.4.5. Recent Initiatives (2017-2019)
11.5. Recordati S.p.A.
11.5.1. Company Snapshot
11.5.2. Company Overview
11.5.3. Financial Performance (2015-2019)
11.5.3.1. Net Revenue
11.5.3.2. Gross Profit
11.5.3.3. Geographical Revenue, 2019
11.5.4. Product Offerings
11.5.5. Recent Initiatives (2017-2019)
11.6. Koninklijke DSM N.V.
11.6.1. Company Snapshot
11.6.2. Company Overview
11.6.3. Financial Performance (2015-2019)
11.6.3.1. Net Revenue
11.6.3.2. Gross Profit
11.6.3.3. Geographical Revenue, 2019
11.6.4. Product Offerings
11.6.5. Recent Initiatives (2017-2019)
11.7. Sanofi
11.7.1. Company Snapshot
11.7.2. Company Overview
11.7.3. Financial Performance (2015-2019)
11.7.3.1. Net Revenue
11.7.3.2. Gross Profit
11.7.3.3. Geographical Revenue, 2019
11.7.4. Product Offerings
11.7.5. Recent Initiatives (2017-2019)
11.8. Shine Star (Hubei) Biological Engineering Co.
11.8.1. Company Snapshot
11.8.2. Company Overview
11.8.3. Financial Performance (2015-2019)
11.8.3.1. Net Revenue
11.8.3.2. Gross Profit
11.8.3.3. Geographical Revenue, 2019
11.8.4. Product Offerings
11.8.5. Recent Initiatives (2017-2019)
11.9. Civentichem, LLC
11.9.1. Company Snapshot
11.9.2. Company Overview
11.9.3. Financial Performance (2015-2019)
11.9.3.1. Net Revenue
11.9.3.2. Gross Profit
11.9.3.3. Geographical Revenue, 2019
11.9.4. Product Offerings
11.9.5. Recent Initiatives (2017-2019)
11.10. Kyowa Hakko Kirin Co., Ltd.
11.10.1. Company Snapshot
11.10.2. Company Overview
11.10.3. Financial Performance (2015-2019)
11.10.3.1. Net Revenue
11.10.3.2. Gross Profit
11.10.3.3. Geographical Revenue, 2019
11.10.4. Product Offerings
11.10.5. Recent Initiatives (2017-2019)
11.11. Other Notable Players
12. Conclusion
13. Glossary
Associated Visiongain Reports
Visiongain Report Sales Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6 Amino Acid Metabolism Disorders Treatment Market Drivers & Restraints 2020
Table 7 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 8 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 9 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 10 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 11 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 12 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17 Vitamin B6&B12 Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 18 Vitamin B6&B12 Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 19 Vitamin B6&B12 Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 20 Vitamin B6&B12 Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 21 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 22 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 23 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 24 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 25 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 26 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 27 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 28 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 29 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 30 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 31 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 32 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 33 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 34 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 35 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 36 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 37 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 38 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 39 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 40 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 41 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 42 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 43 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 44 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 45 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 46 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 47 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 48 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 49 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 50 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 51 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 52 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 53 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 54 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 55 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 56 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 57 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 58 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 59 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 60 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 61 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 62 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 63 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 64 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 65 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 66 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 67 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 68 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 69 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 70 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 71 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 72 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 73 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 74 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 75 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 76 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 77 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 78 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 79 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 80 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 81 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 82 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 83 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 84 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 85 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 86 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 87 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 88 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 89 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 90 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 91 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 92 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 93 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 94 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 95 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 96 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 97 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 98 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 99 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 100 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 101 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 102 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 103 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 104 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 105 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 106 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 107 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 108 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 109 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 110 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 111 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 112 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 113 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 114 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 115 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 116 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 117 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 118 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 119 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 120 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 121 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 122 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 123 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 124 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 125 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 126 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 127 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 128 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 129 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 130 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 131 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 132 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 133 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 134 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 135 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 136 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 137 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 138 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 139 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 140 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 141 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 142 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 143 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 144 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 145 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 146 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 147 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 148 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 149 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 150 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 151 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 152 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 153 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 154 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 155 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 156 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 157 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 158 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 159 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 160 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 161 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 162 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 163 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 164 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 165 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 166 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 167 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 168 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 169 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 170 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 171 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 172 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 173 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 174 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 175 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 176 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 177 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 178 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 179 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 180 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 181 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 182 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 183 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 184 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 185 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 186 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 187 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 188 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 189 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 190 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 191 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 192 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 193 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 194 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 195 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 196 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 197 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 198 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 199 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 200 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 201 Leading 10 Amino Acid Metabolism Disorders Treatment Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 202 GlaxoSmithKline PLC Profile 2019 (CEO, HQ, Founded, Website)
Table 203 GlaxoSmithKline PLC Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2019 (Date, Contract Treatment Type, Details)
Table 204 GlaxoSmithKline PLC Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 205 Pfizer, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 206 Pfizer, Inc. Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2019 (Date, Contract Treatment Type, Details)
Table 207 Pfizer, Inc. Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 208 AMINO GmbH Profile 2019 (CEO, HQ, Founded, Website)
Table 209 AMINO GmbH Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2017-2019 (Date, Contract Treatment Type, Details)
Table 210 AMINO GmbH Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 211 Merck KGaA Profile 2019 (CEO, HQ, Founded, Website)
Table 212 Merck KGaA Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2015-2019 (Date, Contract Treatment Type, Details)
Table 213 Merck KGaA Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 214 Recordati S.p.A. Profile 2019 (CEO, HQ, Founded, Website)
Table 215 Recordati S.p.A. Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2015-2019 (Date, Contract Treatment Type, Details)
Table 216 Recordati S.p.A. Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 217 Koninklijke DSM N.V. Profile 2019 (CEO, HQ, Founded, Website)
Table 218 Koninklijke DSM N.V. Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2015-2019 (Date, Contract Treatment Type, Details)
Table 219 Koninklijke DSM N.V. Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 220 Sanofi Profile 2019 (CEO, HQ, Founded, Website)
Table 221 Sanofi Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2015-2019 (Date, Contract Treatment Type, Details)
Table 222 Sanofi Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 223 Shine Star (Hubei) Biological Engineering Co. Profile 2019 (CEO, HQ, Founded, Website)
Table 224 Shine Star (Hubei) Biological Engineering Co. Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2015-2019 (Date, Contract Treatment Type, Details)
Table 225 Shine Star (Hubei) Biological Engineering Co. Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 226 Civentichem, LLC Profile 2019 (CEO, HQ, Founded, Website)
Table 227 Civentichem, LLC Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2015-2019 (Date, Contract Treatment Type, Details)
Table 228 Civentichem, LLC Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 229 Kyowa Hakko Kirin Co., Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 230 Kyowa Hakko Kirin Co., Ltd. Amino Acid Metabolism Disorders Treatment Selected Recent Contracts 2015-2019 (Date, Contract Treatment Type, Details)
Table 231 Kyowa Hakko Kirin Co., Ltd. Amino Acid Metabolism Disorders Treatment Product Offering (Segment, Product Offerings)
Table 232 Other Companies Involved in the Amino Acid Metabolism Disorders Treatment Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1 Amino Acid Metabolism Disorders Treatment Market By Product Type Overview
Figure 2 Amino Acid Metabolism Disorders Treatment Market By Distribution Channel
Figure 3 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 4 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 5 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 6 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 7 Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 8 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 9 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 10 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 11 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 12 Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 13 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 14 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 15 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 16 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 17 Folic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 18 Vitamin B6&B12 Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19 Vitamin B6&B12 Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20 Vitamin B6&B12 Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21 Vitamin B6&B12 Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26 Arginine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31 Thiamine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36 Vitamin D Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41 Betaine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46 Sapropterin Dihydrochloride Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51 Carglumic Acid Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56 Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61 Hospital Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66 Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71 Online StoresSubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 73 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 74 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 75 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 76 Regional Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 77 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 78 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 79 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 80 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 81 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 82 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 83 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 84 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 85 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 86 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 87 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 88 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 89 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 90 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 91 North America Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 92 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 93 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 94 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 95 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 96 US Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 97 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 98 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 99 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 100 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 101 Canada Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 102 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 103 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 104 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 105 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 106 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 107 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 108 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 109 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 110 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 111 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 112 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 113 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 114 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 115 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 116 Europe Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 117 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 118 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 119 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 120 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 121 UK Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 122 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 123 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 124 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 125 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 126 Germany Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 127 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 128 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 129 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 130 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 131 France Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 132 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 133 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 134 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 135 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 136 Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 137 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 138 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 139 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 140 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 141 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 142 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 143 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 144 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 145 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 146 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 147 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 148 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 149 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 150 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 151 Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 152 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 153 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 154 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 155 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 156 China Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 157 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 158 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 159 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 160 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 161 India Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 162 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 163 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 164 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 165 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 166 Japan Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 167 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 168 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171 RoAPAC Amino Acid Metabolism Disorders Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 173 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181 Middle East Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 183 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 184 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 185 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 186 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 187 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 188 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 189 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 190 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 191 Latin America Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 192 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 193 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 194 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 195 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 196 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 197 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 198 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 199 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 200 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 201 Africa Amino Acid Metabolism Disorders Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Companies Profiled in the Report
1. GlaxoSmithKline PLC
2. Pfizer, Inc.
3. AMINO GmbH
4. Merck KGaA, Recordati S.p.A.
5. Koninklijke DSM N.V.
6. Sanofi
7. Shine Star (Hubei) Biological Engineering Co.
8. Civentichem, LLC, Ltd.
9. Kyowa Hakko Kirin Co., Ltd.
10. Meda Consumer Healthcare Inc.
List of Companies Mentioned in the Report:
1. Shionogi & Co.
2. Shanghai Fosun Pharmaceutical
3. Stada Arzneimittel
4. Lundbeck
5. Zhejiang International
6. Lupin
7. Taisho Pharmaceutical
8. Tasly Pharmaceutical
9. Ipsen
10. Sino Biopharmaceutical
11. Ono Pharmaceutical
12. Aurobindo
13. Cipla
14. Johnson & Johnson
15. Roche
16. Novartis
17. Sanofi
18. Bayer
19. Merck & Co. (MSD)
20. Eli Lilly
21. Astrazeneca
22. Teva
23. CR Pharmaceutical
24. Bristol-Myers Squibb
25. Merck (KGaA)
26. Novo Nordisk
27. Takeda
28. Allergan
29. Astellas Pharma
30. Mylan
31. Otsuka
32. Daiichi Sankyo
33. Valeant Pharmaceuticals
34. UCB
35. Zoetis
36. Eisai
37. Chugai Pharmaceutical
38. Perrigo
39. Sun Pharmaceutical
40. Mitsubishi Tanabe Pharma
41. Sichuan Languang Development
42. Sumitomo Dainippon Pharma
43. Yunnan Baiyao
44. Aspen Pharmacare
45. Endo
46. Kangmei Pharmaceutical
47. Galenica
48. Guangzhou Baiyunshan Pharmaceutical
49. Kyowa Hakko Kirin
50. Mallinckrod
List of Organizations Mentioned in the Report:
1. European Commission
2. European Medicines Agency
3. Food and Drug Administration
4. Medicines and Healthcare Regulatory Agency
5. Ministry of Industry and Information technology
6. National Institute of Health
7. World Health Organisation (WHO)
8. Centers for Disease Control and Prevention
9. National Academy of Medicine
10. Agency for Healthcare Research and Quality
11. National Accreditation Board for Hospitals & Healthcare Providers
12. National Institute for Health Research
13. Chinese Food and Drug Administration
14. Care Quality Commission
15. British Medical Association
16. United States Department of Health and Human Services
17. Healthcare Information and Management Systems Society
18. Patient safety organization
19. NHS Digital
20. Australian Commission On Safety And Quality In Health Care
1. GlaxoSmithKline PLC
2. Pfizer, Inc.
3. AMINO GmbH
4. Merck KGaA, Recordati S.p.A.
5. Koninklijke DSM N.V.
6. Sanofi
7. Shine Star (Hubei) Biological Engineering Co.
8. Civentichem, LLC, Ltd.
9. Kyowa Hakko Kirin Co., Ltd.
10. Meda Consumer Healthcare Inc.
List of Companies Mentioned in the Report:
1. Shionogi & Co.
2. Shanghai Fosun Pharmaceutical
3. Stada Arzneimittel
4. Lundbeck
5. Zhejiang International
6. Lupin
7. Taisho Pharmaceutical
8. Tasly Pharmaceutical
9. Ipsen
10. Sino Biopharmaceutical
11. Ono Pharmaceutical
12. Aurobindo
13. Cipla
14. Johnson & Johnson
15. Roche
16. Novartis
17. Sanofi
18. Bayer
19. Merck & Co. (MSD)
20. Eli Lilly
21. Astrazeneca
22. Teva
23. CR Pharmaceutical
24. Bristol-Myers Squibb
25. Merck (KGaA)
26. Novo Nordisk
27. Takeda
28. Allergan
29. Astellas Pharma
30. Mylan
31. Otsuka
32. Daiichi Sankyo
33. Valeant Pharmaceuticals
34. UCB
35. Zoetis
36. Eisai
37. Chugai Pharmaceutical
38. Perrigo
39. Sun Pharmaceutical
40. Mitsubishi Tanabe Pharma
41. Sichuan Languang Development
42. Sumitomo Dainippon Pharma
43. Yunnan Baiyao
44. Aspen Pharmacare
45. Endo
46. Kangmei Pharmaceutical
47. Galenica
48. Guangzhou Baiyunshan Pharmaceutical
49. Kyowa Hakko Kirin
50. Mallinckrod
List of Organizations Mentioned in the Report:
1. European Commission
2. European Medicines Agency
3. Food and Drug Administration
4. Medicines and Healthcare Regulatory Agency
5. Ministry of Industry and Information technology
6. National Institute of Health
7. World Health Organisation (WHO)
8. Centers for Disease Control and Prevention
9. National Academy of Medicine
10. Agency for Healthcare Research and Quality
11. National Accreditation Board for Hospitals & Healthcare Providers
12. National Institute for Health Research
13. Chinese Food and Drug Administration
14. Care Quality Commission
15. British Medical Association
16. United States Department of Health and Human Services
17. Healthcare Information and Management Systems Society
18. Patient safety organization
19. NHS Digital
20. Australian Commission On Safety And Quality In Health Care
Download sample pages
Complete the form below to download your free sample pages for Amino Acid Metabolism Disorders Treatment Market Report to 2031Download sample pages
Complete the form below to download your free sample pages for Amino Acid Metabolism Disorders Treatment Market Report to 2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033
The global Vaccine Contract Manufacturing Market is projected to grow at a CAGR of 13.2% by 2033
24 May 2023
Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033
The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15% by 2033
23 May 2023
Visiongain Publishes Single-use Bioprocessing Probes & Sensors Market Report 2023-2033
The global Single-Use Bioprocessing Probes & Sensors market was valued US$2,493.8 million in 2022 and is projected to grow at a CAGR of 15.2% during the forecast period 2023-2033.
22 May 2023
Visiongain Publishes Dental Consumables Market Report 2023-2033
The global Dental Consumables market is valued at US$21,759.4 million in 2023 and is expected to register a CAGR of 8% from 2023 to 2033.
22 May 2023
